CCK-8S inhibits L-dopa-induced dyskinesias in parkinsonian squirrel monkeys.
Systemic administration of CCK-8S (1 or 10 micrograms/kg IP) markedly inhibited L-dopa-induced dyskinesias in parkinsonian monkeys, but did not interfere with locomotor stimulation by L-dopa. CCK analogues may be useful antidyskinetic agents for improved control of Parkinson's disease.
Egile Nagusiak: | Boyce, S, Rupniak, N, Steventon, M, Iversen, S |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
1990
|
Antzeko izenburuak
-
Characterisation of dyskinesias induced by L-dopa in MPTP-treated squirrel monkeys.
nork: Boyce, S, et al.
Argitaratua: (1990) -
Nigrostriatal damage is required for induction of dyskinesias by L-DOPA in squirrel monkeys.
nork: Boyce, S, et al.
Argitaratua: (1990) -
Dystonia induced by combined treatment with L-dopa and MK-801 in parkinsonian monkeys.
nork: Rupniak, N, et al.
Argitaratua: (1992) -
(+)-PHNO: a new anti-parkinsonian agent which does not induce chorea in MPTP-treated squirrel monkeys.
nork: Rupniak, N, et al.
Argitaratua: (1990) -
NB-355: a novel prodrug for L-DOPA with reduced risk for peak-dose dyskinesias in MPTP-treated squirrel monkeys.
nork: Tye, S, et al.
Argitaratua: (1989)